Swiss National Bank Has $48.25 Million Stock Position in Avantor, Inc. (NYSE:AVTR)

Swiss National Bank cut its position in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 2.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 2,113,600 shares of the company's stock after selling 57,800 shares during the quarter. Swiss National Bank owned 0.31% of Avantor worth $48,253,000 as of its most recent filing with the SEC.

Several other hedge funds also recently modified their holdings of AVTR. Boston Partners increased its position in shares of Avantor by 21.4% during the 3rd quarter. Boston Partners now owns 28,077,026 shares of the company's stock valued at $588,362,000 after purchasing an additional 4,948,951 shares during the period. Invesco Ltd. boosted its stake in shares of Avantor by 56.5% during the 3rd quarter. Invesco Ltd. now owns 6,591,898 shares of the company's stock worth $138,957,000 after acquiring an additional 2,381,154 shares in the last quarter. Public Sector Pension Investment Board boosted its stake in shares of Avantor by 65.6% during the 3rd quarter. Public Sector Pension Investment Board now owns 2,538,995 shares of the company's stock worth $53,522,000 after acquiring an additional 1,005,480 shares in the last quarter. abrdn plc boosted its stake in shares of Avantor by 777.4% during the 4th quarter. abrdn plc now owns 951,775 shares of the company's stock worth $21,729,000 after acquiring an additional 843,298 shares in the last quarter. Finally, Adage Capital Partners GP L.L.C. bought a new stake in shares of Avantor during the 3rd quarter worth $16,864,000. 95.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Avantor

In other Avantor news, EVP James Bramwell sold 6,203 shares of the firm's stock in a transaction dated Tuesday, February 27th. The stock was sold at an average price of $24.49, for a total transaction of $151,911.47. Following the transaction, the executive vice president now directly owns 101,143 shares in the company, valued at $2,476,992.07. The transaction was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 1.30% of the company's stock.

Avantor Stock Down 0.1 %

Shares of NYSE:AVTR traded down $0.03 during midday trading on Tuesday, hitting $24.85. 3,842,866 shares of the stock were exchanged, compared to its average volume of 5,733,097. The company has a debt-to-equity ratio of 0.94, a quick ratio of 1.05 and a current ratio of 1.61. Avantor, Inc. has a 52-week low of $16.63 and a 52-week high of $26.16. The business's fifty day simple moving average is $25.11 and its two-hundred day simple moving average is $22.80. The company has a market capitalization of $16.88 billion, a PE ratio of 63.71, a P/E/G ratio of 1.50 and a beta of 1.36.

Avantor (NYSE:AVTR - Get Free Report) last announced its quarterly earnings data on Friday, April 26th. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.20 by $0.02. Avantor had a return on equity of 13.01% and a net margin of 3.79%. The business had revenue of $1.68 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same period last year, the company earned $0.29 earnings per share. Avantor's quarterly revenue was down 5.6% compared to the same quarter last year. As a group, research analysts predict that Avantor, Inc. will post 1.01 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on AVTR. JPMorgan Chase & Co. raised their price objective on Avantor from $26.00 to $29.00 and gave the stock an "overweight" rating in a research note on Thursday, February 15th. Citigroup raised their price objective on Avantor from $24.00 to $30.00 and gave the stock a "buy" rating in a research note on Thursday, February 15th. Barclays raised their target price on Avantor from $27.00 to $30.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 10th. Robert W. Baird decreased their target price on Avantor from $27.00 to $26.00 and set an "outperform" rating for the company in a research report on Monday, April 29th. Finally, Royal Bank of Canada raised their target price on Avantor from $28.00 to $29.00 and gave the stock an "outperform" rating in a research report on Thursday, February 15th. Four analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $26.71.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.